601 related articles for article (PubMed ID: 18986535)
21. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis.
Glabinski AR; Tani M; Tuohy VK; Tuthill RJ; Ransohoff RM
Brain Behav Immun; 1995 Dec; 9(4):315-30. PubMed ID: 8903849
[TBL] [Abstract][Full Text] [Related]
23. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.
Kihara Y; Ishii S; Kita Y; Toda A; Shimada A; Shimizu T
J Exp Med; 2005 Sep; 202(6):853-63. PubMed ID: 16172262
[TBL] [Abstract][Full Text] [Related]
24. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
De Paula ML; Rodrigues DH; Teixeira HC; Barsante MM; Souza MA; Ferreira AP
Int Immunopharmacol; 2008 Sep; 8(9):1291-7. PubMed ID: 18602076
[TBL] [Abstract][Full Text] [Related]
25. The use of chemokine antagonists in EAE models.
Proudfoot AE; de Souza AL; Muzio V
J Neuroimmunol; 2008 Jul; 198(1-2):27-30. PubMed ID: 18550179
[TBL] [Abstract][Full Text] [Related]
26. Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.
Zaheer S; Wu Y; Yang X; Ahrens M; Sahu SK; Zaheer A
Neurochem Int; 2012 Feb; 60(3):215-9. PubMed ID: 22226840
[TBL] [Abstract][Full Text] [Related]
27. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
Dutra RC; Moreira EL; Alberti TB; Marcon R; Prediger RD; Calixto JB
Brain Behav Immun; 2013 Oct; 33():90-101. PubMed ID: 23777652
[TBL] [Abstract][Full Text] [Related]
28. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
29. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
30. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice.
Heneka MT; Sharp A; Murphy P; Lyons JA; Dumitrescu L; Feinstein DL
J Neurochem; 2001 Apr; 77(2):568-79. PubMed ID: 11299319
[TBL] [Abstract][Full Text] [Related]
31. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR
Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267
[TBL] [Abstract][Full Text] [Related]
32. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
33. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
[TBL] [Abstract][Full Text] [Related]
34. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
Ford ML; Evavold BD
Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
[TBL] [Abstract][Full Text] [Related]
35. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
36. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.
Karpus WJ; Kennedy KJ
J Leukoc Biol; 1997 Nov; 62(5):681-7. PubMed ID: 9365124
[TBL] [Abstract][Full Text] [Related]
37. PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome.
Berod L; Heinemann C; Heink S; Escher A; Stadelmann C; Drube S; Wetzker R; Norgauer J; Kamradt T
Eur J Immunol; 2011 Mar; 41(3):833-44. PubMed ID: 21287545
[TBL] [Abstract][Full Text] [Related]
38. Induction of glial L-CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis.
Brouwer N; Zuurman MW; Wei T; Ransohoff RM; Boddeke HW; Biber K
Glia; 2004 Apr; 46(1):84-94. PubMed ID: 14999816
[TBL] [Abstract][Full Text] [Related]
39. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
40. Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.
Gaupp S; Pitt D; Kuziel WA; Cannella B; Raine CS
Am J Pathol; 2003 Jan; 162(1):139-50. PubMed ID: 12507897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
